Yann Izarzugaza
Madrid, MD, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Efficacy of anti-PD1 therapy in PD1-high mRNA tumors across multiple cancer types: results from cohort 1 and cohort 2 of the phase II SOLTI-1904 ACROPOLI trial.
Journal: ESMO open
Published: June 16, 2025
Generation and Characterization of Trastuzumab/Pertuzumab-Resistant HER2-Positive Breast Cancer Cell Lines.
Journal: International journal of molecular sciences
Published: November 13, 2023
Patritumab deruxtecan in HER2-negative breast cancer: part B results of the window-of-opportunity SOLTI-1805 TOT-HER3 trial and biological determinants of early response.
Journal: Nature communications
Published: September 18, 2023
Patritumab deruxtecan in untreated hormone receptor-positive/HER2-negative early breast cancer: final results from part A of the window-of-opportunity SOLTI TOT-HER3 pre-operative study.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: April 04, 2023
Tumor-Infiltrating Lymphocytes and Immune Response in HER2-Positive Breast Cancer.
Journal: Cancers
Published: October 17, 2022
SOLTI-1904 ACROPOLI TRIAL: efficacy of spartalizumab monotherapy across tumor-types expressing high levels of PD1 mRNA.
Journal: Future oncology (London, England)
Published: October 06, 2022
Pre-operative ribociclib plus letrozole versus chemotherapy: Health-related quality of life outcomes from the SOLTI CORALLEEN trial.
Journal: European journal of cancer (Oxford, England : 1990)
Published: June 20, 2022
Ribociclib plus letrozole versus chemotherapy for postmenopausal women with hormone receptor-positive, HER2-negative, luminal B breast cancer (CORALLEEN): an open-label, multicentre, randomised, phase 2 trial.
Journal: The Lancet. Oncology
Published: October 09, 2019
Late Administration of Trastuzumab Emtansine Might Lead to Loss of Chance for Better Outcome in Patients with HER2-Positive Metastatic Breast Cancer.
Journal: Breast care (Basel, Switzerland)
Published: October 16, 2018
Prognostic value of Ki-67 according to age in patients with triple-negative breast cancer.
Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Published: January 29, 2018
Showing 1-10 of 10
Last Updated: 09/26/2026